医疗ETF华宝(512170)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-2,575,461,972.08 |
1,501,970,660.40 |
535,263,357.36 |
-3,695,187,294.90 |
| 利息合计 |
520,513.31 |
1,153,901.71 |
530,886.41 |
18,571,674.00 |
| 其中:存款利息收入 |
520,513.31 |
1,153,901.71 |
530,886.41 |
1,234,971.47 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-945,321,447.04 |
-1,654,014,447.60 |
-1,594,594,403.38 |
-3,420,915,675.14 |
| 其中:股票投资收益 |
-1,167,442,278.84 |
-2,024,567,441.19 |
-1,860,814,806.47 |
-3,775,434,554.25 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
222,120,831.80 |
370,552,993.59 |
266,220,403.09 |
354,518,879.11 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-1,646,463,974.93 |
3,127,032,417.11 |
2,115,325,732.68 |
-329,725,733.20 |
| 其他收入 |
15,802,936.58 |
27,798,789.18 |
14,001,141.65 |
36,882,439.44 |
| 费用 |
80,431,013.19 |
156,562,911.71 |
77,207,676.78 |
148,329,768.90 |
| 管理人报酬 |
66,941,317.46 |
128,950,538.09 |
62,899,786.82 |
117,498,840.15 |
| 基金托管费 |
13,388,263.51 |
25,790,107.63 |
12,579,957.38 |
23,499,767.96 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
101,362.61 |
1,822,265.99 |
1,727,932.58 |
7,268,746.69 |
| 利润总额 |
-2,655,892,985.27 |
1,345,407,748.69 |
458,055,680.58 |
-3,843,517,063.80 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年